Macquarie Upgrades Pharma Research (214450:KS) to Outperform

August 25, 2026 3:55 AM EDT Send to a Friend
Macquarie analyst Jun Choi upgraded Pharma Research (214450:KS) from Neutral to Outperform with a price target of KRW520,000.00 (from KRW390,000.00).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login